Merit Medical Systems $747.5 million convertible senior notes offering
The 3% convertible senior notes are due 2029
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
Evolent Health $402.5 million convertible notes offering
The convertible notes are due 2029
Innovent Biologics HK$2.4 billion placement of shares
The shares are listed on the Hong Kong Stock Exchange
Atara Biotherapeutics $100 million at-the-market offering
The stock is listed on Nasdaq
WuXi XDC Cayman HK$3.68 billion IPO
The shares are listed on the HKEX
Bristol Myers Squibb $4.5 billion notes offering
The investment-grade offering comprised four tranches
Alector $125 million at-the-market offering
The common stock is listed on the Nasdaq Global Select Market
NeuroPace $50 million at-the-market offering
The stock is listed on the Nasdaq Global Market
Forbion European Acquisition $138 million combination with enGene
We advised Forbion European Acquisition on its de-SPAC transaction
IDEAYA Biosciences $143.8 million equity offering
The common stock is listed on the Nasdaq Global Select Market